Inari Medical (NARI) News Today $79.55 +0.15 (+0.19%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Stryker Launches Tender Offer To Acquire Inari Medical For $80/shrJanuary 18 at 1:44 AM | markets.businessinsider.comHere’s Why Inari Medical Inc. (NARI) Led This Week’s RallyJanuary 13, 2025 | msn.comWilliam Blair downgrades Inari Medical (NARI) to a HoldJanuary 11, 2025 | markets.businessinsider.comInari Medical (NASDAQ:NARI) Given "Market Perform" Rating at William BlairJanuary 10, 2025 | americanbankingnews.comInari Medical (NASDAQ:NARI) Rating Lowered to "Hold" at Baird R WJanuary 10, 2025 | americanbankingnews.comBTIG Research Reiterates "Neutral" Rating for Inari Medical (NASDAQ:NARI)January 10, 2025 | americanbankingnews.comInari Medical, Inc. (NASDAQ:NARI) Receives $61.80 Consensus PT from BrokeragesJanuary 10, 2025 | americanbankingnews.comInari Medical (NASDAQ:NARI) Stock Price Expected to Rise, Piper Sandler Analyst SaysJanuary 9, 2025 | americanbankingnews.comInari Medical Sees Unusually Large Options Volume (NASDAQ:NARI)January 9, 2025 | americanbankingnews.comInari Medical (NASDAQ:NARI) Receives "Hold" Rating from Canaccord Genuity GroupJanuary 9, 2025 | americanbankingnews.comInari Medical (NASDAQ:NARI) Hits New 52-Week High After Analyst UpgradeJanuary 9, 2025 | americanbankingnews.comInari Medical, Inc. (NASDAQ:NARI) Director Sells $12,094,000.00 in StockInari Medical, Inc. (NASDAQ:NARI - Get Free Report) Director William Hoffman sold 200,000 shares of the company's stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $60.47, for a total value of $12,094,000.00. Following the completion of the transaction, the director now directly owns 238,987 shares in the company, valued at $14,451,543.89. The trade was a 45.56 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.January 8, 2025 | marketbeat.comBTIG Research Reiterates Neutral Rating for Inari Medical (NASDAQ:NARI)BTIG Research reaffirmed a "neutral" rating on shares of Inari Medical in a research report on Wednesday.January 8, 2025 | marketbeat.comInari Medical (NASDAQ:NARI) Lowered to Hold Rating by Baird R WBaird R W downgraded shares of Inari Medical from a "strong-buy" rating to a "hold" rating in a research report on Tuesday.January 8, 2025 | marketbeat.comInari Medical's (NARI) Equal Weight Rating Reiterated at Wells Fargo & CompanyJanuary 8, 2025 | americanbankingnews.comStryker Corporation Signs Definitive Agreement to Acquire Inari Medical Inc. for $80 per ShareJanuary 8, 2025 | americanbankingnews.comHold Rating Issued for Inari Medical Amidst Stryker Acquisition with Minimal Antitrust Concerns and Reasonable ValuationJanuary 7, 2025 | markets.businessinsider.comINARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARIJanuary 7, 2025 | businesswire.comInari Medical downgraded to Hold from Buy at JefferiesJanuary 7, 2025 | markets.businessinsider.comDevice maker Stryker strikes $4.9 billion deal for Inari MedicalJanuary 7, 2025 | msn.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Inari Medical, Inc. BuyoutJanuary 7, 2025 | markets.businessinsider.comInari Medical (NASDAQ:NARI) Earns Equal Weight Rating from Wells Fargo & CompanyWells Fargo & Company reissued an "equal weight" rating and issued a $80.00 price objective (up from $65.00) on shares of Inari Medical in a report on Tuesday.January 7, 2025 | marketbeat.com$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inari Medical, Inc. - NARIJanuary 7, 2025 | prnewswire.comStryker’s Strategic Acquisition of Inari Medical: A Catalyst for Growth in the Peripheral Vascular MarketJanuary 7, 2025 | markets.businessinsider.comThese Stocks Are Moving the Most Today: Nvidia, Micron, Uber, Carvana, Inari Medical, Getty Images, and MoreJanuary 7, 2025 | msn.comInari Medical Catapults — Again — After Stryker Confirms $4.9 Billion DealJanuary 7, 2025 | yahoo.comStryker Buying Inari Medical in $4.9B Deal to Boost Vascular BusinessJanuary 7, 2025 | finance.yahoo.comInari Medical Target of Unusually Large Options Trading (NASDAQ:NARI)Inari Medical, Inc. (NASDAQ:NARI - Get Free Report) was the target of some unusual options trading on Tuesday. Traders purchased 11,622 call options on the stock. This represents an increase of approximately 2,174% compared to the average volume of 511 call options.January 7, 2025 | marketbeat.comInari Medical's (NARI) "Market Perform" Rating Reiterated at William BlairWilliam Blair reaffirmed a "market perform" rating on shares of Inari Medical in a report on Tuesday.January 7, 2025 | marketbeat.comInari Medical (NASDAQ:NARI) Sets New 12-Month High on Analyst UpgradeInari Medical (NASDAQ:NARI) Sets New 12-Month High After Analyst UpgradeJanuary 7, 2025 | marketbeat.comPiper Sandler Forecasts Strong Price Appreciation for Inari Medical (NASDAQ:NARI) StockPiper Sandler increased their target price on shares of Inari Medical from $52.00 to $80.00 and gave the company a "neutral" rating in a research report on Tuesday.January 7, 2025 | marketbeat.comInari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9BJanuary 7, 2025 | investopedia.comCanaccord Genuity Group Reaffirms Hold Rating for Inari Medical (NASDAQ:NARI)Canaccord Genuity Group reissued a "hold" rating and set a $80.00 price target (up from $74.00) on shares of Inari Medical in a report on Tuesday.January 7, 2025 | marketbeat.comRobert W. Baird Reaffirms Neutral Rating for Inari Medical (NASDAQ:NARI)Robert W. Baird reiterated a "neutral" rating and set a $80.00 price target (down from $81.00) on shares of Inari Medical in a research note on Tuesday.January 7, 2025 | marketbeat.comCautious Hold: Evaluating Inari Medical’s Acquisition by Stryker Amidst Growth Deceleration and Market UncertaintiesJanuary 7, 2025 | markets.businessinsider.comThese Stocks Are Moving the Most Today: Nvidia, Micron, Uber, FuboTV, Inari Medical, Denali Therapeutics, and MoreJanuary 7, 2025 | msn.comInari Medical, Inc. (NASDAQ:NARI) Given Consensus Recommendation of "Moderate Buy" by BrokeragesInari Medical, Inc. (NASDAQ:NARI - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve research firms that are currently covering the company, MarketBeat reports. Six research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendJanuary 7, 2025 | marketbeat.comHealth Care Flat Amid Deal Activity, Regulation Fears -- Health Care RoundupJanuary 6, 2025 | marketwatch.comHere’s Why Inari Medical Inc. (NASDAQ:NARI) Is SkyrocketingJanuary 6, 2025 | msn.comNARI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inari Medical, Inc. Is Fair to ShareholdersJanuary 6, 2025 | businesswire.comShareholder Alert: Ademi LLP investigates whether Inari Medical, Inc. is obtaining a Fair Price for its Public ShareholdersJanuary 6, 2025 | businesswire.comExclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources sayJanuary 6, 2025 | reuters.comInari Medical, Inc. (NASDAQ:NARI) Shares Sold by JPMorgan Chase & Co.JPMorgan Chase & Co. lessened its stake in Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 4.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,123,602 shares of the company's stock after selling 47,878 sharesJanuary 6, 2025 | marketbeat.comInari Medical (NASDAQ:NARI) Shares Down 4.2% - Should You Sell?Inari Medical (NASDAQ:NARI) Trading Down 4.2% - What's Next?January 3, 2025 | marketbeat.comInari Medical to Present at the J.P. Morgan Healthcare ConferenceJanuary 3, 2025 | globenewswire.comInari Medical, Inc. (NASDAQ:NARI) Short Interest Up 25.3% in DecemberInari Medical, Inc. (NASDAQ:NARI - Get Free Report) saw a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 3,660,000 shares, a growth of 25.3% from the November 30th total of 2,920,000 shares. Based on an average daily volume of 940,700 shares, the days-to-cover ratio is currently 3.9 days.December 30, 2024 | marketbeat.comInari Medical (NASDAQ:NARI) Stock Price Down 4.6% Following Insider SellingInari Medical (NASDAQ:NARI) Stock Price Down 4.6% After Insider SellingDecember 23, 2024 | marketbeat.comInari Medical, Inc. (NASDAQ:NARI) CEO Sells $165,870.00 in StockInari Medical, Inc. (NASDAQ:NARI - Get Free Report) CEO Andrew Hykes sold 3,000 shares of the business's stock in a transaction on Friday, December 20th. The shares were sold at an average price of $55.29, for a total value of $165,870.00. Following the transaction, the chief executive officer now owns 439,310 shares of the company's stock, valued at approximately $24,289,449.90. The trade was a 0.68 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.December 20, 2024 | marketbeat.comInari Medical, Inc. (NASDAQ:NARI) Shares Acquired by Jane Street Group LLCJane Street Group LLC increased its holdings in shares of Inari Medical, Inc. (NASDAQ:NARI - Free Report) by 32.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 95,223 shares of the company's stock afterDecember 19, 2024 | marketbeat.comInari Medical, Inc. (NASDAQ:NARI) Director William Hoffman Sells 60,000 SharesInari Medical, Inc. (NASDAQ:NARI - Get Free Report) Director William Hoffman sold 60,000 shares of the firm's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $55.66, for a total value of $3,339,600.00. Following the transaction, the director now owns 441,233 shares of the company's stock, valued at $24,559,028.78. This trade represents a 11.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.December 18, 2024 | marketbeat.com Get Inari Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter. Email Address NARI Media Mentions By Week NARI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NARI News Sentiment▼0.230.64▲Average Medical News Sentiment NARI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NARI Articles This Week▼210▲NARI Articles Average Week Get Inari Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NARI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Solventum News Today Smith & Nephew News Today Penumbra News Today Glaukos News Today Stevanato Group News Today Bausch + Lomb News Today Inspire Medical Systems News Today PROCEPT BioRobotics News Today Envista News Today iRhythm Technologies News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NARI) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredInvesting Tools You’ll Need for 2025Investing Tools You’ll Need for 2025 Charles Payne Shares His #1 Strategy for 2025 Unstoppable Prosperity | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inari Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inari Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.